Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, Ireland, January 21, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/t5gv76/strategic) has announced the addition of the "Strategic Analysis of the Global In Vitro Diagnostics Market - Stagnating Local Markets Accelerate the Globalization of In Vitro Diagnostics Companies" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Despite global economic and industry challenges, In vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry.
This deliverable research leverages primary and secondary sources of global research. Market segments include immunochemistry, self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), molecular diagnostics, hematology, clinical microbiology, and hemostasis. Regions include United States, Western Europe, Asia-Pacific, Latin America, and Eastern Europe. Each segment includes revenue forecasts for 2009 to 2017, market share, competitive landscape, and product analysis.
Key Questions This Study Will Answer:
Key Topics Covered:
Total IVD Market
Immunochemistry Segment Breakdown
Self-Monitoring Blood Glucose Segment Breakdown
Point-of-Care Testing Segment Breakdown
Molecular Diagnostics Segment Breakdown
Hematology Segment Breakdown
Clinical Microbiology Segment Breakdown
Hemostasis Segment Breakdown
The Last Word
For more information visit http://www.researchandmarkets.com/research/t5gv76/strategic
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
©2012 PR Newswire. All Rights Reserved.